Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]

1994 • 6,495 citations

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

1993 • 5,539 citations

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1975 • 3,051 citations

Clinical staging of chronic lymphocytic leukemia

1975 • 2,706 citations

Interpreting the significance of changes in health-related quality-of-life scores.

1998 • 2,659 citations

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1997 • 1,799 citations

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

2001 • 996 citations

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1998 • 769 citations

Multiple myeloma; a review of 26 cases.

1957 • 682 citations

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma study group

1995 • 480 citations

Erythropoietin Treatment of Anemia Associated with Multiple Myeloma

1990 • 459 citations

Factors influencing quality of life in cancer patients: anemia and fatigue.

1998 • 386 citations

Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system

1996 • 360 citations

Clinical staging of chronic lymphocytic leukemia

1975 • 325 citations

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

1995 • 226 citations

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma

1996 • 210 citations

Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]

1994 • 194 citations

Importance of iron supply for erythropoietin therapy

1995 • 155 citations

Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]

1994 • 131 citations

Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer.

1998 • 83 citations

Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.

1996 • 75 citations

Role of iron in optimizing responses of anemic cancer patients to erythropoietin.

1999 • 59 citations

Recombinant Human Erythropoietin in the Treatment of Multiple Myeloma-Associated Anemia

1997 • 57 citations

Prediction of response to recombinant human erythropoietin (r- HuEPO/epoetin-alpha) therapy in cancer patients [letter; comment]

1995 • 57 citations

MACULAR HAEMORRHAGE IN ADULT ACUTE LEUKAEMIA PATIENTS AT PRESENTATION AND THE RISK OF SUBSEQUENT INTRACRANIAL HAEMORRHAGE

1997 • 27 citations

Impact of anemia and fatigue on quality of life in cancer patients: a brief review.

1998 • 18 citations

Assessing the impact of cancer-related anaemia on quality of life and the role of rHuEPO.

2000 • 15 citations